These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3371392)

  • 1. Effect of controlled-release metoprolol on blood pressure and exercise heart rate in hypertension: a comparison with conventional tablets.
    Rydén L; Kristensson BE; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S33-7. PubMed ID: 3371392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of a new controlled-release formulation of metoprolol: a comparison with conventional metoprolol tablets in mild to moderate hypertension.
    Houtzagers JJ; Smilde JG; Creytens G; Westergren G
    Eur J Clin Pharmacol; 1988; 33 Suppl():S39-44. PubMed ID: 3371393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of a controlled release (CR/ZOK) formulation of metoprolol, once daily, with conventional metoprolol tablets, twice daily, in mild to moderate hypertension.
    Carruthers G; Shearer R; Taylor W; Moore M
    J Clin Pharmacol; 1990 Feb; 30(S2):S61-5. PubMed ID: 2179282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of once-daily metoprolol controlled-release and atenolol in the treatment of Chinese patients with mild to moderate hypertension.
    Chen MF; Yang CY; Chen WJ; Lee CM; Wu CC; Liau CS; Lee YT
    Cardiovasc Drugs Ther; 1995 Jun; 9(3):401-6. PubMed ID: 8527349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of metoprolol CR/ZOK 50 mg and atenolol 50 mg once daily for uncomplicated hypertension.
    Klein G; Berger J; Olsson G; Menzel T
    J Clin Pharmacol; 1990 Feb; 30(S2):S72-7. PubMed ID: 2179284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK once daily with conventional tablets once daily and in divided doses.
    Lücker P; Moore G; Wieselgren I; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S17-27. PubMed ID: 2312775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metoprolol administered once daily in the treatment of hypertension. A double-blind crossover comparison between conventional tablets and metoprolol Durules.
    Asplund J; Ohman P
    Ann Clin Res; 1981; 13 Suppl 30():30-6. PubMed ID: 7027891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic properties of a new controlled-release formulation of metoprolol: a comparison with conventional tablets.
    Sandberg A; Blomqvist I; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S9-14. PubMed ID: 3371395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slow-release metoprolol in angina pectoris. A comparative study of a cardioselective beta-blocking drug, metoprolol, in ordinary and slow-release tablets (Durules) in the treatment of angina pectoris.
    Uusitalo AJ; Keyriläinen O
    Ann Clin Res; 1979 Oct; 11(5):199-204. PubMed ID: 44671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of controlled-release metoprolol: a comparison with atenolol.
    Blomqvist I; Westergren G; Sandberg A; Jonsson UE; Lundborg P
    Eur J Clin Pharmacol; 1988; 33 Suppl():S19-24. PubMed ID: 3371390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antianginal efficacy and tolerability of controlled-release metoprolol once daily: a comparison with conventional metoprolol tablets twice daily.
    Egstrup K; Gundersen T; Härkönen R; Karlsson E; Lundgren B
    Eur J Clin Pharmacol; 1988; 33 Suppl():S45-9. PubMed ID: 3371394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CNS-related subjective symptoms in hypertensive patients treated with either a new controlled release (CR/ZOK) formulation of metoprolol or atenolol.
    Dimenäs E; Ostergren J; Lindvall K; Dahlöf C; Westergren G; de Faire U
    J Clin Pharmacol; 1990 Feb; 30(S2):S82-90. PubMed ID: 2179286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
    Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of low dose metoprolol CR/ZOK in mild hypertension and in elderly patients with mild to moderate hypertension.
    Jäättelä A; Baandrup S; Houtzagers J; Westergren G
    J Clin Pharmacol; 1990 Feb; 30(S2):S66-71. PubMed ID: 2179283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.
    Oosterhuis B; Jonkman JH; Kerkhof FA
    Eur J Clin Pharmacol; 1988; 33 Suppl():S15-8. PubMed ID: 3371389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacokinetic and pharmacodynamic comparison of metoprolol CR/ZOK with a conventional slow release preparation.
    Oosterhuis B; Jonkman J; Zuiderwijk P; Sollie F
    J Clin Pharmacol; 1990 Feb; 30(S2):S33-8. PubMed ID: 2312777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind crossover comparative study of the efficacy of single daily doses of conventional and slow-release metoprolol.
    Nievel JG; Harvard CW
    Curr Med Res Opin; 1981; 7(8):503-15. PubMed ID: 7030636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacokinetic and pharmacodynamic comparison of immediate-release metoprolol and extended-release metoprolol CR/XL in patients with suspected acute myocardial infarction: a randomized, open-label study.
    Karlson BW; Dellborg M; Gullestad L; Aberg J; Sugg J; Herlitz J
    Cardiology; 2014; 127(2):73-82. PubMed ID: 24247812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of a fixed combination of metoprolol CR/ZOK 100 mg and hydrochlorothiazide (HCT) 12.5 mg in comparison with the fixed combination of metoprolol and HCT.
    Leikersfeldt G; Rasmussen SL; Atmer B; Hjalmers S; Wahlqvist I
    J Clin Pharmacol; 1990 Feb; 30(S2):S78-81. PubMed ID: 2179285
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic evaluation of metoprolol controlled release (CR/ZOK) 50 mg in young subjects.
    Wieselgren I; Lundborg P; Sandberg A; Olofsson B; Bergstrand R
    J Clin Pharmacol; 1990 Feb; 30(S2):S28-32. PubMed ID: 2312776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.